The beta-carbolines (harmanes) - a new class of endogenous compounds: their relevance for the pathogenesis and treatment of psychiatric and neurological diseases.
D000470:Alkaloids / Q000502:physiology*; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D001569:Benzodiazepines; D002243:Carbolines / Q000502:physiology*; D000431:Ethanol / Q000494:pharmacology; D006247:Harmine / Q000031:analogs & derivatives / Q000502:physiology*; D006801:Humans; D007211:Indoles / Q000502:physiology*; D008519:Medicine, Traditional; D001523:Mental Disorders / Q000188:drug therapy / Q000503:physiopathology*; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology*; D011619:Psychotropic Drugs / Q000494:pharmacology
D000470:Alkaloids; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D002243:Carbolines; D007211:Indoles; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D000431:Ethanol; D006247:Harmine; C005010:harman